152 related articles for article (PubMed ID: 37304941)
1. The Effect of Timeliness of Care on Lung Cancer Survival - A Population-Based Approach.
Guerreiro T; Mayer A; Aguiar P; Araújo A; Nunes C
Ann Glob Health; 2023; 89(1):39. PubMed ID: 37304941
[TBL] [Abstract][Full Text] [Related]
2. Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy.
Ha D; Ries AL; Montgrain P; Vaida F; Sheinkman S; Fuster MM
Respir Med; 2018 Aug; 141():172-179. PubMed ID: 30053964
[TBL] [Abstract][Full Text] [Related]
3. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer survival and sex-specific patterns in Portugal: A population-based analysis.
Guerreiro T; Forjaz G; Antunes L; Bastos J; Mayer A; Aguiar P; Araújo A; Nunes C
Pulmonology; 2023 Dec; 29 Suppl 4():S70-S79. PubMed ID: 34642125
[TBL] [Abstract][Full Text] [Related]
5. Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non-Small-Cell Lung Cancer in South Carolina.
Bullard JT; Eberth JM; Arrington AK; Adams SA; Cheng X; Salloum RG
South Med J; 2017 Feb; 110(2):107-113. PubMed ID: 28158880
[TBL] [Abstract][Full Text] [Related]
6. Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands.
van de Ven M; Retèl VP; Koffijberg H; van Harten WH; IJzerman MJ
Lung Cancer; 2019 Aug; 134():34-41. PubMed ID: 31319992
[TBL] [Abstract][Full Text] [Related]
7. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older.
Driessen E; Detillon D; Bootsma G; De Ruysscher D; Veen E; Aarts M; Janssen-Heijnen M
J Geriatr Oncol; 2019 Jul; 10(4):547-554. PubMed ID: 30876833
[TBL] [Abstract][Full Text] [Related]
8. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancer.
Laerum D; Brustugun OT; Gallefoss F; Falk R; Strand TE; Fjellbirkeland L
Cancer Treat Res Commun; 2021; 29():100477. PubMed ID: 34700140
[TBL] [Abstract][Full Text] [Related]
10. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
11. Time to treatment in patients with stage III non-small cell lung cancer.
Wang L; Correa CR; Hayman JA; Zhao L; Cease K; Brenner D; Arenberg D; Curtis J; Kalemkerian GP; Kong FM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):790-5. PubMed ID: 19231108
[TBL] [Abstract][Full Text] [Related]
12. Impact of Targeted Therapy on the Survival of Patients With Advanced-Stage Non-small Cell Lung Cancer in Oncosalud - AUNA.
Aguilar A; Mas L; Enríquez D; Vallejos C; Gutarra R; Flores CJ
Cancer Control; 2022; 29():10732748211068637. PubMed ID: 35030060
[TBL] [Abstract][Full Text] [Related]
13. Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study.
Klarenbeek SE; Aarts MJ; van den Heuvel MM; Prokop M; Tummers M; Schuurbiers OCJ
Thorax; 2023 May; 78(5):467-475. PubMed ID: 35450944
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
15. Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma.
Hester CA; Karbhari N; Rich NE; Augustine M; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Singal AG; Yopp AC
Cancer; 2019 Oct; 125(19):3428-3436. PubMed ID: 31299089
[TBL] [Abstract][Full Text] [Related]
16. Timeliness of care in patients with lung cancer: a systematic review.
Olsson JK; Schultz EM; Gould MK
Thorax; 2009 Sep; 64(9):749-56. PubMed ID: 19717709
[TBL] [Abstract][Full Text] [Related]
17. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
[TBL] [Abstract][Full Text] [Related]
18. Timeliness of care and prognosis in patients with lung cancer.
Gonzalez-Barcala FJ; Falagan JA; Garcia-Prim JM; Valdes L; Carreira JM; Puga A; Martín-Lancharro P; Garcia-Sanz MT; Anton-Sanmartin D; Canive-Gomez JC; Pose-Reino A; Lopez-Lopez R
Ir J Med Sci; 2014 Sep; 183(3):383-90. PubMed ID: 24091615
[TBL] [Abstract][Full Text] [Related]
19. The effect of a lung cancer care coordination program on timeliness of care.
Alsamarai S; Yao X; Cain HC; Chang BW; Chao HH; Connery DM; Deng Y; Garla VN; Hunnibell LS; Kim AW; Obando JA; Taylor C; Tellides G; Rose MG
Clin Lung Cancer; 2013 Sep; 14(5):527-34. PubMed ID: 23827516
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]